Fosfomycin Export Market Intelligence: India's 73 Suppliers Shipping to 46 Countries — TransData Nexus 2026

Q: Who are the top fosfomycin exporters from India?

The top fosfomycin exporters from India are: 1. CIPLA LIMITED — $9.6M (74.5% market share); 2. SWISS PARENTERALS LIMITED — $1.6M (12.5% market share); 3. SRS PHARMACEUTICALS PRIVATE LIMITED — $285.3K (2.2% market share); 4. AMNEAL PHARMACEUTICALS PRIVATE LIMITED — $215.4K (1.7% market share); 5. AVANTIKA MEDEX PRIVATE LIMITED — $172.6K (1.3% market share). Together they account for 92.3% of India's total fosfomycin export value.

Q: What is the total export value of fosfomycin from India?

The total export value of fosfomycin from India is $12.9M USD, recorded across 492 shipment transactions from 73 active exporters to 46 destination countries. The average shipment value is $26.2K.

Q: Which countries import fosfomycin from India?

India exports fosfomycin to 46 countries worldwide. The top importing countries are: UNITED STATES (76.9% share, $9.9M), GERMANY (9.3% share, $1.2M), GUATEMALA (3.9% share, $505.6K), TUNISIA (3.9% share, $497.4K), UZBEKISTAN (1.3% share, $172.6K). These five markets account for 95.4% of total export value.

Q: What is the HS code for fosfomycin exports from India?

The primary HS code for fosfomycin exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of fosfomycin exports from India?

The average unit price for fosfomycin exports from India is $12.03 USD per unit, with prices ranging from $0.03 to $977.62 depending on formulation, packaging, and order volume. The total market is valued at $12.9M across 492 shipments.

Q: Which ports handle fosfomycin exports from India?

The primary ports for fosfomycin exports from India are SAHAR AIR CARGO ACC (INBOM4) (20.1% of shipments), DELHI AIR CARGO ACC (INDEL4) (17.5% of shipments), SAHAR AIR (15.7% of shipments), DELHI AIR (10.2% of shipments), Bombay Air (4.9% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of fosfomycin?

India is one of the world's leading exporters of fosfomycin due to its large base of 73 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports fosfomycin to 46 countries, demonstrating 24% global market coverage.

Q: What certifications do Indian fosfomycin exporters need?

Indian fosfomycin exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import fosfomycin from India?

There are 88 registered buyers importing fosfomycin from India, spread across 46 countries. The repeat buyer rate is 51.1%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top fosfomycin supplier from India?

CIPLA LIMITED is the leading fosfomycin exporter from India with a market share of 74.5% and total export value of $9.6M across 120 shipments. The top 5 suppliers together control 92.3% of total export value.

Suresh Sormare

Fosfomycin

India Pharmaceutical Trade Intelligence

$12.9M73 Suppliers46 CountriesHS 30049099

ExportsIndia → UNITED STATES76.9%India → GERMANY9.3%

ImportsSWITZERLAND → India$74.5M ITALY → India$539.8K

#1 Supplier: CIPLA LIMITED #1 Buyer: CIPLA USA

Fosfomycin Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Fosfomycin to the World

Between 2022 and 2026, India exported $12.9M worth of fosfomycin across 492 verified shipments to 46 countries — covering 24% of world markets in the Advanced Antibiotics segment. The largest destination is UNITED STATES (76.9%). CIPLA LIMITED leads with a 74.5% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Fosfomycin export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Fosfomycin export data snapshot — $12.9M · 73 exporters · 46 countriesTransData Nexus · Indian Customs Data

Top Fosfomycin Exporters from India

73 active exporters · Ranked by export value

View all 73 →

Top Fosfomycin Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	CIPLA LIMITED	$9.6M	120	2	74.5%
2	SWISS PARENTERALS LIMITED

Top Countries Importing Fosfomycin from India

46 destination markets · Ranked by import value

All 46 countries →

Top Countries Importing Fosfomycin from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$9.9M	76.9%
2	GERMANY	$1.2M	9.3%
3	GUATEMALA	$505.6K	3.9%
4	TUNISIA	$497.4K	3.9%
5	UZBEKISTAN	$172.6K	1.3%
6	RUSSIA	$111.6K	0.9%
7	BOSNIA AND HERZEGOVINA	$88.7K	0.7%
8	ECUADOR	$62.4K	0.5%
9	LEBANON	$46.8K	0.4%
10	VENEZUELA	$35.4K	0.3%

UNITED STATES is India's largest fosfomycin export destination, absorbing 76.9% of total exports worth $9.9M. The top 5 importing countries — UNITED STATES, GERMANY, GUATEMALA, TUNISIA, UZBEKISTAN — together account for 95.4% of India's total fosfomycin export value. The remaining 41 destination countries collectively receive the other 4.6%, indicating a focused distribution strategy targeting key markets.

Who Supplies Fosfomycin to India?

9 origin countries · Total import value: $75.1M

India imports fosfomycin from 9 countries with a combined import value of $75.1M. The largest supplier is SWITZERLAND ($74.5M, 16 shipments), followed by ITALY and UNITED STATES. All values are from Indian Customs (DGFT) import records.

Countries Supplying Fosfomycin to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	SWITZERLAND	$74.5M	16	99.2%
2	ITALY	$539.8K	3	0.7%
3	UNITED STATES	$37.5K	14	0.0%
4	UNITED KINGDOM	$12.0K	9	0.0%
5	AUSTRALIA	$2.0K	2	0.0%
6	GERMANY	$764	1	0.0%
7	CANADA	$686	1	0.0%
8	FRANCE	$618	1	0.0%
9	BRAZIL	$507	3	0.0%

SWITZERLAND is the largest supplier of fosfomycin to India, accounting for 99.2% of total import value. The top 5 origin countries — SWITZERLAND, ITALY, UNITED STATES, UNITED KINGDOM, AUSTRALIA — together supply 100.0% of India's fosfomycin imports. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Fosfomycin

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, fosfomycin is approved for the treatment of uncomplicated urinary tract infections. The FDA has approved several Abbreviated New Drug Applications (ANDAs) for generic versions of fosfomycin tromethamine. Notably, Alkem Laboratories Ltd. received approval on October 21, 2021, Amneal Pharmaceuticals on March 25, 2024, and Aurobindo Pharma Ltd. on November 14, 2025. These approvals have facilitated the entry of Indian exporters into the U.S. market, with Amneal Pharmaceuticals Private Limited contributing 1.7% to India's fosfomycin exports.

The regulatory pathway for fosfomycin in the U.S. involves demonstrating bioequivalence to the reference listed drug, Monurol. As of February 2026, all formulations of Monurol have been discontinued, yet generic versions remain available. There are no current import alerts or significant regulatory actions affecting fosfomycin imports from India, indicating a stable regulatory environment for Indian exporters.

2EU & UK Regulatory Framework

In the European Union, fosfomycin is authorized for use in treating various bacterial infections. The European Medicines Agency (EMA) oversees the approval process, ensuring compliance with EU Good Manufacturing Practice (GMP) standards. Similarly, in the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) regulates the marketing authorization of fosfomycin, adhering to stringent GMP requirements. Indian exporters must meet these standards to access the EU and UK markets.

3WHO Essential Medicines & Global Standards

Fosfomycin is not included in the WHO Model List of Essential Medicines as of the 24th edition published in September 2025. However, it is recognized in various pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring standardized quality and efficacy across different markets.

4India Regulatory Classification

In India, fosfomycin is classified under Schedule H of the Drugs and Cosmetics Act, requiring a prescription for dispensation. The National Pharmaceutical Pricing Authority (NPPA) has not set a ceiling price for fosfomycin, allowing market-driven pricing. For exports, the Directorate General of Foreign Trade (DGFT) mandates a No Objection Certificate (NOC) to ensure compliance with national regulations and international standards.

5Patent & Exclusivity Status

The primary patents for fosfomycin have expired, leading to increased generic competition. This has enabled multiple Indian pharmaceutical companies to manufacture and export fosfomycin, contributing to the diversification and growth of India's pharmaceutical export portfolio.

6Recent Industry Developments

In March 2024, Amneal Pharmaceuticals received FDA approval for its generic version of fosfomycin tromethamine, enhancing the availability of this antibiotic in the U.S. market. Subsequently, in November 2025, Aurobindo Pharma Ltd. also secured FDA approval for its generic formulation, further intensifying competition among Indian exporters.

In January 2026, the WHO published the 24th edition of its Model List of Essential Medicines, which did not include fosfomycin. This exclusion may influence procurement decisions in certain markets, potentially affecting demand dynamics for Indian exporters.

Overall, the regulatory landscape for fosfomycin exported from India remains favorable, with established approvals in key markets and adherence to international quality standards. Indian exporters continue to play a pivotal role in supplying fosfomycin globally, leveraging their manufacturing capabilities and regulatory compliance.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Fosfomycin

Retail & reference prices across 9 markets vs. India FOB export price of $12.03/unit

Global Price Benchmark for Fosfomycin across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	Not specified	USD	According to the FDA Orange Book, Fosfomycin Tromethamine is approved in a 3g granules for oral solution formulation.
United Kingdom	Approximately $6.50 per 3g sachet	GBP	As listed in the NHS Drug Tariff, July 2025.
Germany	Not specified	EUR	Specific pricing information is not readily available from public regulatory sources.
Australia	Not specified	AUD

Supply Chain Risk Assessment — Fosfomycin

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

Fosfomycin, an antibiotic used to treat bacterial infections, is primarily manufactured in India. However, the production of its Active Pharmaceutical Ingredient (API) often relies on Key Starting Materials (KSMs) sourced from China. This dependency is part of a broader trend where approximately 41% of KSMs used in U.S.-approved APIs are solely sourced from China, and 16% from India, according to the U.S. Pharmacopeia's Medicine Supply Map.

Recent geopolitical tensions have exacerbated supply chain vulnerabilities. In February 2026, military escalations in the Middle East led to the effective shutdown of the Strait of Hormuz, a critical passage for global trade. This disruption has significantly impacted the supply of raw materials, including those essential for pharmaceutical manufacturing, leading to production cutbacks and force majeure declarations in the chemical industry.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates a high concentration in Fosfomycin exports from India. The top five exporters account for 92.3% of the total export value, with CIPLA LIMITED alone contributing 74.5%. Such concentration poses a significant single-source risk, as any disruption affecting these key suppliers could severely impact global supply.

To mitigate this risk, the Indian government has implemented the Production Linked Incentive (PLI) scheme, aiming to boost domestic production of critical APIs and reduce reliance on imports. In October 2024, two greenfield plants were inaugurated under this scheme to manufacture essential molecules like Penicillin G and 6-APA, marking a significant step towards self-sufficiency.

Access Complete Fosfomycin Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 492 transactions across 46 markets.

Request Demo View Pricing

Frequently Asked Questions — Fosfomycin Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top fosfomycin exporters from India?

The leading fosfomycin exporters from India are CIPLA LIMITED, SWISS PARENTERALS LIMITED, SRS PHARMACEUTICALS PRIVATE LIMITED, and 5 others. CIPLA LIMITED leads with 74.5% market share ($9.6M). The top 5 suppliers together control 92.3% of total export value.

What is the total export value of fosfomycin from India?

The total export value of fosfomycin from India is $12.9M, recorded across 492 shipments from 73 active exporters to 46 countries. The average shipment value is $26.2K.

Which countries import fosfomycin from India?

India exports fosfomycin to 46 countries. The top importing countries are UNITED STATES (76.9%), GERMANY (9.3%), GUATEMALA (3.9%), TUNISIA (3.9%), UZBEKISTAN (1.3%), which together account for 95.4% of total export value.

What is the HS code for fosfomycin exports from India?

The primary HS code for fosfomycin exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Fosfomycin

Fosfomycin

Top Fosfomycin Exporters from India

Top Countries Importing Fosfomycin from India

Who Supplies Fosfomycin to India?

Quick Facts

Related Advanced Antibiotics

Related Analysis

Need Details?

Regulatory Landscape — Fosfomycin

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Fosfomycin

Supply Chain Risk Assessment — Fosfomycin

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Fosfomycin Trade Intelligence

Frequently Asked Questions — Fosfomycin Exports from India

Who are the top fosfomycin exporters from India?

What is the total export value of fosfomycin from India?

Which countries import fosfomycin from India?

What is the HS code for fosfomycin exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of fosfomycin exports from India?

Which ports handle fosfomycin exports from India?

Why is India a leading exporter of fosfomycin?

What certifications do Indian fosfomycin exporters need?

How many buyers import fosfomycin from India?

What is the market share of the top fosfomycin exporter from India?

Analysis Methodology